IDECABTAGENE VICLEUCEL vs IFOSFAMIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDECABTAGENE VICLEUCEL vs IFOSFAMIDE: Safety Overview
| Metric | IDECABTAGENE VICLEUCEL | IFOSFAMIDE |
|---|---|---|
| Total FAERS Reports | 1,037 | 17,004 |
| Deaths Reported | 137 | 3,365 |
| Death Rate | 13.2% | 19.8% |
| Hospitalizations | 356 | 5,230 |
| Average Patient Age | 65.3 yrs | 36.2 yrs |
| % Female Patients | 41.9% | 41.7% |
| FDA Approval Date | N/A | Apr 4, 2007 |
| Manufacturer | Celgene Corporation | Baxter Healthcare Corporation |
| Route | INTRAVENOUS | INTRAVENOUS |
| Marketing Status | N/A | Prescription |